• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价运动药物检测中福莫特罗的尿阈浓度。

Evaluation of the urinary threshold concentration of formoterol in sports drug testing.

机构信息

Bioanalysis Research Group, IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003, Barcelona, Spain.

出版信息

Drug Test Anal. 2013 Apr;5(4):266-9. doi: 10.1002/dta.1450. Epub 2013 Jan 25.

DOI:10.1002/dta.1450
PMID:23355217
Abstract

The use of formoterol in sports is allowed by inhalation at the maximum recommended therapeutic dose. Recently, a threshold concentration of 30 ng.mL(-1) was defined by the World Anti-Doping Agency (WADA) to distinguish between therapeutic and forbidden use of formoterol. The objective of this work was to evaluate that threshold concentration. Concentrations of formoterol were measured in urine samples collected after administration of 18 µg of inhaled formoterol to five healthy volunteers, and in samples collected in routine doping tests belonging to athletes having declared inhaled formoterol use. Formoterol was detected up to 8 h after administration in all volunteers with concentrations up to 19.6 ng.mL(-1) . From 28 routine samples, 27 had less than 10 ng.mL(-1) of formoterol and only in one of the samples the concentration was 25 ng.mL(-1) . Therefore, administration of formoterol by inhalation at the maximum dose allowed by WADA will not produce false positive results using a threshold concentration of 30 ng.mL(-1) , and the experience up to now in routine doping tests indicates that the probability of obtaining urines with concentrations greater than 30 ng.mL(-1) is close to nil. For this reason, sports authorities should re-evaluate the need of a threshold concentration for formoterol and its practical usefulness.

摘要

福莫特罗在运动中的使用允许通过最大推荐治疗剂量的吸入。最近,世界反兴奋剂机构(WADA)定义了 30ng.mL(-1) 的阈值浓度,以区分福莫特罗的治疗性和禁用使用。本工作的目的是评估该阈值浓度。在 5 名健康志愿者吸入 18μg 福莫特罗后采集的尿液样本中测量了福莫特罗的浓度,并在运动员申报吸入福莫特罗使用的常规兴奋剂检测样本中进行了测量。在所有志愿者中,在给药后 8 小时内均检测到福莫特罗,浓度高达 19.6ng.mL(-1)。在 28 个常规样本中,只有 1 个样本的浓度为 25ng.mL(-1),浓度低于 10ng.mL(-1)。因此,在 WADA 允许的最大剂量下通过吸入给予福莫特罗不会产生假阳性结果,使用 30ng.mL(-1) 的阈值浓度,并且迄今为止在常规兴奋剂检测中的经验表明,获得浓度大于 30ng.mL(-1)的尿液的概率接近零。因此,体育当局应重新评估福莫特罗的阈值浓度及其实际用途的必要性。

相似文献

1
Evaluation of the urinary threshold concentration of formoterol in sports drug testing.评价运动药物检测中福莫特罗的尿阈浓度。
Drug Test Anal. 2013 Apr;5(4):266-9. doi: 10.1002/dta.1450. Epub 2013 Jan 25.
2
Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis.定量检测人尿中吸入的福莫特罗及其与兴奋剂检测分析的相关性。
Drug Test Anal. 2012 Jun;4(6):449-54. doi: 10.1002/dta.418. Epub 2012 Mar 22.
3
Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.血液和尿液中的福莫特罗浓度:世界反兴奋剂机构 2012 年规定。
Med Sci Sports Exerc. 2013 Jan;45(1):16-22. doi: 10.1249/MSS.0b013e318269fba2.
4
Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control.(R,R)-福莫特罗、(S,S)-福莫特罗及其各自葡糖苷酸在单次吸入给药后的尿中对映体处置及在兴奋剂检测中的应用。
Drug Test Anal. 2019 Jul;11(7):950-956. doi: 10.1002/dta.2587. Epub 2019 Apr 22.
5
The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis.在兴奋剂检测分析方面,单次吸入1600微克沙丁胺醇后,运动和脱水对其尿液浓度的影响。
Drug Test Anal. 2016 Jul;8(7):613-20. doi: 10.1002/dta.1828. Epub 2015 Jun 4.
6
Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine.建立并验证了一种超高效液相色谱-串联质谱法,用于直接检测人尿液中的福莫特罗。
J Pharm Biomed Anal. 2012 Nov;70:471-5. doi: 10.1016/j.jpba.2012.06.042. Epub 2012 Jul 7.
7
Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control.吸入给药后尿中(R)-沙美特罗和(S)-沙美特罗的对映体选择性分布及其在兴奋剂检测中的应用
Drug Test Anal. 2017 Aug;9(8):1262-1266. doi: 10.1002/dta.2131. Epub 2016 Dec 29.
8
Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes.调整运动员沙丁胺醇反兴奋剂政策的医学和药理学方法。
Respir Res. 2015 Dec 24;16:155. doi: 10.1186/s12931-015-0315-2.
9
The enigma of inhaled salbutamol and sport: unresolved after 45 years.吸入沙丁胺醇与运动之谜:45年后仍未解决。
Drug Test Anal. 2017 Jul;9(7):977-982. doi: 10.1002/dta.2184. Epub 2017 May 12.
10
Impact of ethnicity, gender, and dehydration on the urinary excretion of inhaled salbutamol with respect to doping control.种族、性别和脱水对吸入沙丁胺醇尿排泄量在兴奋剂检测方面的影响。
Clin J Sport Med. 2014 Nov;24(6):482-9. doi: 10.1097/JSM.0000000000000072.

引用本文的文献

1
Beta2-Agonist Doping Control and Optical Isomer Challenges.β2-激动剂兴奋剂检测与光学异构体挑战。
Sports Med. 2016 Dec;46(12):1787-1795. doi: 10.1007/s40279-016-0547-4.